Marrone Bio Innovations

Receive alerts
Market Cap:
$171.35 m
1.23 USD
52 weeks high
52 weeks low

In brief

Marrone Bio Innovations Inc. (NASDAQ: MBII) is a growth company leading the movement to more a sustainable world through the discovery, development and sale of innovative biological products for crop protection, plant health and waterway systems treatment that help customers operate more sustainably while increasing their return on investment. MBI has screened over 18,000 microorganisms and 350 plant extracts, leveraging our in-depth knowledge of plant and soil microbiomes enhanced by advanced molecular technologies and natural product chemistry to rapidly develop seven product lines. Supported by a robust portfolio of over 400 issued and pending patents, MBI’s currently available commercial products are Regalia®, Stargus®, Grandevo®, Venerate®, Majestene®, Haven® and Amplitude®, Zelto® and Zequanox®. MBI also has a breakthrough bioherbicide and biofumigant in the pipeline.

Deep dive We explore the investor case for growth companies


The company's biopesticides unleash "Bio with bite" on an industry that has long been overdependent on chemical pesticides